Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease

Journal of Cardiopulmonary Rehabilitation
Y LacasseF Maltais

Abstract

To measure the prevalence rate of significant depressive symptoms and depression and examine their consequences on quality of life in patients with severe oxygen-dependent chronic obstructive pulmonary disease (COPD). Between November 1997 and March 1998, the authors conducted a cross-sectional study among the COPD patients registered at the Quebec City area respiratory home care service. Depression and quality of life were assessed using the Geriatric Depression Scale and the Medical Outcome Survey--Short Form 36 (SF-36). 109 patients (63 men; mean age: 71) with severe COPD (median FEV1: 34%) were surveyed. Of them, 105 were on long-term oxygen therapy (LTOT), which had been introduced (median) 19 months earlier. Sixty-two patients (57%; 95% Cl: 47-66) demonstrated significant depressive symptoms; in addition, 20 patients (18%; Cl: 12-27) were severely depressed. Only 6% of those patients who met the criteria for depression were taking an antidepressant drug. We found significant and moderate correlations between the scores obtained from the Geriatric Depression Scale and 7 of the 8 domains of the SF-36. Significant depressive symptoms and depression are highly prevalent in patients with severe COPD on LTOT. There is strong ev...Continue Reading

References

Jul 1, 1986·Archives of Internal Medicine·R W LightL R Mutalipassi
Jan 1, 1987·British Journal of Diseases of the Chest·G H GuyattS O Pugsley
May 1, 1983·Chest·R A KinsmanJ Fukuhara
Mar 1, 1982·Archives of Internal Medicine·A J McSweenyR M Timms
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Feb 1, 1995·Medicine and Science in Sports and Exercise·C B Cooper
Apr 15, 1993·Annals of Internal Medicine·G H GuyattD L Patrick
Jun 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A E BonomiR Zittoun
Jan 22, 1997·JAMA : the Journal of the American Medical Association·R M HirschfeldR J Wyatt
May 26, 1997·Archives of Internal Medicine·J L CoulehanE Rodriguez
May 28, 1997·JAMA : the Journal of the American Medical Association·J UnützerW Katon
May 21, 1998·The New England Journal of Medicine·D A RedelmeierG L Booth
Nov 17, 1998·Journal of Clinical Epidemiology·A LeplègeT V Perneger

❮ Previous
Next ❯

Citations

Sep 13, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Patricia P KatzPaul D Blanc
Nov 9, 2004·Patient Education and Counseling·Lisa CicuttoKaty Henderson
Mar 5, 2004·Patient Education and Counseling·Johan B Wempe, Peter J Wijkstra
Mar 5, 2004·Patient Education and Counseling·Martijn A SpruitRik Gosselink
Jun 27, 2007·Journal of Palliative Medicine·Graeme M RockerPaul Hernandez
Apr 23, 2011·Journal of Palliative Medicine·Daisy J A JanssenEmiel F M Wouters
Jun 9, 2006·American Journal of Respiratory and Critical Care Medicine·Linda NiciUNKNOWN ATS/ERS Pulmonary Rehabilitation Writing Committee
Jun 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society
Apr 4, 2009·Clinical Trials : Journal of the Society for Clinical Trials·James A BlumenthalCharles F Emery
Apr 5, 2007·Health and Quality of Life Outcomes·Abebaw Mengistu Yohannes
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Kurt B StageClaus H Sørensen
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Martijn A SpruitUNKNOWN ATS/ERS Task Force on Pulmonary Rehabilitation
Nov 16, 2013·The Psychiatric Clinics of North America·Ondria C GleasonJulia K Warnock
May 29, 2013·The American Journal of Cardiology·Alexis WheelerJohn F Beltrame
Jul 17, 2012·The Medical Clinics of North America·Jonathan P Singer, Roger D Yusen
Jul 12, 2011·Revue des maladies respiratoires·G Ninot
Dec 13, 2005·Revue des maladies respiratoires·F LemoigneC Chouaid
Mar 5, 2016·Lung·Carlos Martinez RiveraMarc Miravitlles
Oct 31, 2007·Clinics in Chest Medicine·Renee D Stapleton, J Randall Curtis
Oct 28, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Harold G Koenig
Nov 29, 2005·Journal of Psychosomatic Research·Kia Minna J HynninenInger Hilde Nordhus
May 21, 2014·NPJ Primary Care Respiratory Medicine·Bernard Aguilaniu, Nicolas Roche
Jul 13, 2007·Respiratory Medicine·Renata A PintoEanes D B Pereira
Aug 28, 2013·International Journal of Psychiatry in Medicine·Todd DoyleJames A Blumenthal
May 26, 2016·Perspectives in Psychiatric Care·Fatih KayhanAyşegül Kayhan
Aug 6, 2016·Respiratory Medicine·Darlan L MatteEmilio Pizzichini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.